Assignee
ENTOS PHARMACEUTICALS INC
CA·5 granted patents·2 pending applications·1 citations·filing 2017–2024
Top patents by PatentIndex Score
7 records- 0175US12454557B2Recombinant polypeptides for membrane fusion and uses thereofENTOS PHARMACEUTICALS INC·Filed 2022·Granted Oct 28, 2025·0 cites·16 claims
- 0275US11459362B2Recombinant polypepties for membrane fusion and uses thereofENTOS PHARMACEUTICALS INC·Filed 2019·Granted Oct 4, 2022·1 cites·8 claims
- 0375US2024374520A1Proteolipid vesicles formulated with fusion associated small transmembrane proteinsENTOS PHARMACEUTICALS INC·Filed 2024·Application pending·0 cites
- 0465US12421514B2Methods for diagnosing and treating metastatic cancerENTOS PHARMACEUTICALS INC·Filed 2021·Granted Sep 23, 2025·0 cites·1 claims
- 0565US2024189232A1Proteolipid vesicles formulated with fusion associated small transmembrane proteinsENTOS PHARMACEUTICALS INC·Filed 2021·Application pending·0 cites
- 0654US11236331B2Methods for diagnosing and treating metastatic cancerENTOS PHARMACEUTICALS INC·Filed 2017·Granted Feb 1, 2022·0 cites·2 claims
- 0747US12378289B2Recombinant oncolytic viruses for treatment of metastatic cancersENTOS PHARMACEUTICALS INC·Filed 2018·Granted Aug 5, 2025·0 cites·5 claims
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →